-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of January 13, Jiangsu Thorpe released the 2021 annual performance forecast.
According to preliminary calculations by the company's financial department, it is expected that the net profit attributable to shareholders of listed companies in 2021 will be between 2.
3 billion and 2.
5 billion yuan, which is similar to the same period in 2020.
An increase of 2.
069 billion to 2.
269 billion yuan over the same period last year, an increase of 894.
34% to 980.
81% year-on-year
.
It is expected that the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses in 2021 will be 2.
28 billion to 2.
48 billion yuan
.
Compared with the same period in 2020, an increase of 2.
039 billion to 2.
239 billion yuan, a year-on-year increase of 845.
47% to 928.
41%
.
Regarding the reasons for the changes in performance, Jiangsu Thorpe will be affected by factors such as the improvement of the market supply and demand relationship and the high prosperity of the domestic chemical industry in 2021.
The prices of the company's main products, acetic acid and derivatives, will increase significantly year-on-year
.
In recent years, the company has continuously promoted the strategy of reducing cost and increasing efficiency, and the level of production process and device control has been continuously improved
.
Under the combined effect of the above factors, the company's performance has risen sharply
.